 LOS GATOS, CA ACCESSWIRE September 14, 2022 Tenon Medical, Inc. NASDAQ:TNON Tenon Medical or the Company, a medical device company that has developed a proprietary, U.S. Food and Drug Administration FDA cleared surgical implant system for sacroiliac joint SI Joint fixationfusion surgery, today announced that management will present during Benzingas All Access investor event taking place Friday, September 16, 2022. Steve Foster, Chief Executive Officer of Tenon Medical, is scheduled to host a presentation and QA session during the event as follows. 